Hong Kong Shuns Oxford-AstraZeneca COVID-19 Vaccines for Johnson & Johnson Amid Fresh Imported Cases

Apr 9, 2021 | EARNINGS

The British-Swedish firm has been hit by numerous crises related to its efficacy as well as concerns voiced by the European Medicines Agency over blood clots triggered by the vaccine.

Read More

Pin It on Pinterest